Cure Alzheimer's Fund Cure Alzheimer's Fund
  • The Disease
    • Pathology
    • Signs & Symptoms
    • Risk Factors
    • Early Onset
    • Dementia
    • Women & Alzheimer’s
    • Detection
    • Stats & Costs
  • The Research
    • Areas of Focus
      • Alzheimer’s Genome Project
      • Genes to Therapy / Stem Cell Screening
      • Identification
      • Immune System Structures & Processes
      • Interaction of the Microbiome
      • Pathological Pathways & Systems
      • Therapeutic Strategies & Drug Discovery
      • Whole Genome Sequencing
      • Other Areas of Investigation
    • Consortia
      • ALZHEIMER’S DISEASE DRUG DISCOVERY & DEVELOPMENT (AD4)
      • FLEMING APOE
      • CIRCUITS
      • BRAIN ENTRY & EXIT
      • NEUROIMMUNE
    • Funded Projects
    • Grant Process
    • Our Researchers
    • Topics of Interest
      • Alzheimer’s in a Dish
      • Amyloid Hypothesis
      • Amyloid Precursor Protein
      • Brain Lymphatic System
      • Innate Immunity
      • Microglia
      • Blood Brain Barrier
    • Published Papers
    • Discoveries
  • About Us
    • Our Story
    • Our People
    • Reports
  • Giving
    • Donate
    • Ways to Donate
      • Planned Giving
    • Our Heroes
    • In Memory & In Honor
    • Artists Giving Back
    • Charity Watchdogs
  • News and Events
    • Events
      • 2018 Symposium Video
    • Webinars
    • Interviews
    • Press
    • Videos
    • Research Newsletter
      • December 2021
      • Fall 2020
      • March 2020
      • November 2019
      • October 2019
      • July 2019
      • March 2019
      • January 2019
      • November 2018
    • Blog
  • Awareness
    • The Face of Alzheimer’s
    • Better Your Brain
    • World Alzheimer’s Day
    • Dr. Solomon Carter Fuller
  • Contact
  • Search
Cure Alzheimer's Fund Cure Alzheimer's Fund
  • 781-237-3800
  • Donate
  • Contact
  • Search

News and Events


Stay updated on the work of our researchers and advances in Alzheimer's science, funding and awareness

CUREALZ

Events

Interviews

News

Press

Videos

Webinars


The Story of Cure Alzheimer’s Fund

Perspectives on How Philanthropy and Venture Capital Must Partner to Translate Lab Discoveries Into Meaningful Benefits for Alzheimer’s Disease Patients

April 8 2022

New Drug for Alzheimer’s Disease – ADUHELM – Update

January 11 2022

2:19 pm

2nd Annual Robert Moir Memorial Lecture, Thursday, January 13th – 3:00PM EST

December 7 2021

Jerome L. Rappaport (August 17, 1927 – December 5, 2021)

December 7 2021

DECREASED EXPRESSION OF CCR7 MAY UNDERLIE AGING-RELATED COGNITIVE DECLINE

December 7 2021

THE EFFECT OF THE MENOPAUSAL TRANSITION PERIOD ON THE BRAIN

December 7 2021

A NEW AND IMPROVED PROTOCOL FOR STUDYING TAUOPATHIES

December 7 2021

REMOVING ASTROCYTIC APOE4 MAY BE BENEFICIAL FOR LATE-STAGE ALZHEIMER’S DISEASE

December 7 2021

APOE4 NEGATIVELY IMPACTS CEREBROVASCULAR FUNCTION

December 7 2021

NEW THERAPEUTIC AVENUES FOR PREVENTING BREAKDOWN OF THE BLOOD-BRAIN BARRIER

December 7 2021

MICROGLIA ARE BUILDING – NOT DESTROYING – DENSE CORE PLAQUES

More

Register for email updates about our latest news:

© 2005 - 2022 Cure Alzheimer's Fund. All rights reserved.

Cure Alzheimer’s Fund is a “doing business as” name for the Alzheimer’s Disease Research Foundation, a 501(c)(3) public charity with federal tax ID #52-239-6428.

Privacy Policy

Donate | 100% goes directly to research

  • Contact
  • 781-237-3800
  • Sitemap